Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
Werte in diesem Artikel
Financial release accessible online
BOSTON, Aug. 7, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information:
- Teleconference link:
https://register-conf.media-server.com/register/BIb1de2bd7b8ba4267b7bc38da4e4008c7 - Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/wv7zkgdh
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
Direct link to 1Q FY26 Earnings Release:
https://haemonetics.gcs-web.com/static-files/078498e0-b75c-4cd4-94fb-93730b3b1c70
A replay of the conference call and webcast will be available for one year beginning on August 7, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website-302523396.html
SOURCE Haemonetics Corporation
Übrigens: Haemonetics und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Haemonetics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Haemonetics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Haemonetics Corp.
Analysen zu Haemonetics Corp.
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.02.2017 | Haemonetics Mkt Perform | Barrington Research | |
07.11.2016 | Haemonetics Hold | The Benchmark Company | |
11.05.2016 | Haemonetics Hold | The Benchmark Company | |
05.11.2015 | Haemonetics Hold | The Benchmark Company | |
16.08.2006 | Update Haemonetics Corp.: Hold | Stanford Research |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Haemonetics Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen